Active Pharmaceutical Ingredients (APIs)







Saltigo at the BOS Forum
API Development - Changing demands and requirements in the design and implementation of work programs associated with both non-clinical and clinical phase development of novel APIs is one of the key topics to be covered in the BOS Forum on Sept. 20 at the Royal College of Physicians in London.












Camelot Management Consultants AG
Rotego Chem
Press'n'Relations GmbH Niederlassung Berlin
Managm. Consult. Chemicals
Veranova
AmbioPharm, Inc.
Bio Evaluation
EXCiPACT
Hovione
SchüllerConsulting
IMCD Group B.V.
Dottikon Exclusive Synthesis AG
SK Pharmteco
Siegfried
CPA Chemical Pharmac. Ass.
Chemwerth
Nanoform
Frost & Sullivan
Cerbios-Pharma SA
Archroma
CMS Advisors GmbH & Co. KG
Cambrex Corporation
FDA Smart
AlixPartners GmbH
DexLeChem GmbH
The Scott Partnership
Azelis Corporate Services NV
Numaferm GmbH
Powder Systems Ltd.
BASF SE
ISPE D/A/CH e.V.
Dishman Europe Ltd.
CatSci Ltd.
Ehrfeld Mikrotechnik GmbH
Roland Berger GmbH
C² PHARMA
IPEC Europe
CONTINUUS Pharmaceuticals, Inc.
EuroAPI
Jan Ramakers Fine Chemical
Curia
Bachem
Johnson Matthey
CHEManager International c/o Wiley-VCH GmbH
Society of Chemical Manufacturers & Affiliates (SOCMA)
gempex GmbH – THE GMP-EXPERT
European Chemical Industry Council - Cefic aisbl
Evonik Nutrition & Care GmbH (Hanau)
Patheon Italia
Cedarburg Hauser Pharmaceuticals






























